1. Home
  2. EDSA vs CYCU Comparison

EDSA vs CYCU Comparison

Compare EDSA & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

N/A

Current Price

$7.04

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Logo Cycurion Inc.

CYCU

Cycurion Inc.

N/A

Current Price

$1.16

Market Cap

7.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EDSA
CYCU
Founded
2015
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
7.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
EDSA
CYCU
Price
$7.04
$1.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$7.00
AVG Volume (30 Days)
7.7M
340.0K
Earning Date
05-13-2026
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.16
52 Week High
$9.37
$7.13

Technical Indicators

Market Signals
Indicator
EDSA
CYCU
Relative Strength Index (RSI) 64.70 29.53
Support Level $1.69 $0.25
Resistance Level $8.74 $2.91
Average True Range (ATR) 1.48 0.16
MACD 0.07 -0.02
Stochastic Oscillator 59.79 22.62

Price Performance

Historical Comparison
EDSA
CYCU

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About CYCU Cycurion Inc.

Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

Share on Social Networks: